What this study is
Einstein Medical Center in Philadelphia serves a diverse group of the patient population. The majority of patients have a diverse cultural background, low literacy, and poor social-economic status. Medication adherence for chronic medical problems is in a range of 40-70%. Medication adherence among patients on oral anti-cancer therapy is not studied in detail. The main objective is to study medication adherence to oral anticancer agents in patients with low literacy and poor socio-economic status.
What's being tested
- Intervention
Intervention · BEHAVIORAL
All participants in this group will receive the standard of care intervention provided by the RN. This includes:Education in the clinic setting,Printed information about the chemotherapy drug and chemotherapy side effects. The RN will be blinded to the arm of study to which each patient is allocated.
Study details
- Official title
- A Randomized, Controlled Trial to Assess Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients in a Socioeconomically Disadvantaged Community
- Sponsor
- Thomas Jefferson University
- Conditions
- Cancer
- Enrolling
- 110 people
- Starts
- 2017-07-20
- Est. completion
- 2026-12-31
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- All patients on oral chemotherapeutic agents
- Clinical diagnosis of stage IV breast cancer
- Clinical diagnosis of stage III and IV colorectal cancer (not receiving concurrent radiation therapy)
- Clinical diagnosis of stage IV non-small cell lung cancer
- Clinical diagnosis of stage IV renal cell carcinoma
- Clinical diagnosis of stage IV ovarian carcinoma
- Clinical diagnosis of multiple myeloma
- Clinical diagnosis of chronic myelogenous leukemia on TKI
- Clinical diagnosis of myelodysplastic syndrome on Lenalidomide
- Adjuvant treatment for Gastro Intestinal Stromal Tumor
- Clinical diagnosis of chronic Lymphocytic Leukemia
- Clinical diagnosis of metastatic Prostate cancer
- Clinical diagnosis of hepatocellular Carcinoma
- Clinical diagnosis of stage IV Melanoma
- Clinical diagnosis of myelofibrosis/myeloproliferative neoplasms
- Age >18 years
- ECOG Performance Status <3
You can't join if
- ECOG Performance Status of 3 and above
- Concurrent chemo radiation
- Non-English speaker
- Clinical diagnosis of dementia, or otherwise unable to give informed consent.
- History of non-compliance (defined as the history of 2 or more missed appointments in the clinic).
- Pregnant patients
- Nursing Home Patients
- Incarcerated
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openAlbert Einstein Healthcare Network
Philadelphia, Pennsylvania, United States
- Claudia M Claudia M Dourado, MD · Contact215-456-3880DouradoC@einstein.edu
- John C Leighton, MD · Contact215-456-3880leightoj@einstein.edu
Recruiting
Study team
Sponsor
Thomas Jefferson University
Study ID 4950
Principal investigator
Claudia M Dourado, MD
Thomas Jefferson University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.